Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$959K Buy
2,060
+457
+29% +$192K 0.01% 1475
2026
Q1
$606K Sell
1,603
-1,205
-43% -$516K ﹤0.01% 1572
2025
Q4
$1.2M Buy
2,808
+2,181
+348% +$949K 0.02% 610
2025
Q3
$281K Buy
+627
New +$284K ﹤0.01% 1613
2020
Q3
Sell
-2,580
Closed -$1.16M 115
2020
Q2
$1.16M Buy
+2,580
New +$1.15M 0.45% 96
2017
Q4
Sell
-3,863
Closed -$781K 97
2017
Q3
$781K Buy
+3,863
New +$759K 0.51% 74

Other funds holding CHE

Empowered Funds's CHE Position: Q2 2026 in Review

Empowered Funds increased its Chemed (CHE) stake by 29% in Q2 2026, buying an estimated $192K and bringing the position to 2,060 shares worth $959K. The position accounts for 0.01% of the portfolio, ranked #1475.

Empowered Funds first reported a position in CHE in Q3 2017 and has held it in 6 quarters since. The position peaked at $1.2M in Q4 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Empowered Funds held 2,060 shares of Chemed worth $959K as of Q2 2026.
  • Empowered Funds bought 457 Chemed shares in Q2 2026, an estimated $192K.
  • Chemed made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1475 holding.
  • Empowered Funds first reported a position in Chemed in Q3 2017 and has held it in 6 quarters since.
  • Empowered Funds's Chemed position peaked at $1.2M in Q4 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.